9月23日全球新冠肺炎(COVID-19)疫情简报,确诊超3174万,第二波疫情死亡率已很低

2020-09-23 MedSci原创 MedSci原创

据Worldometers实时统计数据显示,截至北京时间9月23日06时09分,全球新冠肺炎(COVID-19)确诊病例达3174万例,新增248,321例至31,741,736例,死亡病例达97万例

据Worldometers实时统计数据显示,截至北京时间9月23日06时09分,全球新冠肺炎COVID-19)确诊病例达3174万例,新增248,321例至31,741,736例,死亡病例达97万例,新增4,914例至973,929例,康复23,360,881例,活动病例7,406,926例,其中重症为62,046例。其中美国新冠病毒确诊病例达709万例,新增32,221例至7,094,462例;死亡病例达20万例,新增876例至205,378例。其中印度确诊5,640,496例,新增80,391例。全球确诊病例超过10万例的国家增至37个,摩洛哥成为最新一个超过10万例的国家。此外,荷兰和阿曼的确诊病例也已经超过9万。昨日报道:9月22日全球新冠肺炎(COVID-19)疫情简报,确诊超3145万,世界何时才能对外开放?

当地时间9月22日,世卫组织发布全球各地区疫情数据,全球新冠肺炎确诊病例新增222256例,死亡新增3479例。疫情最为严重的美洲区域确诊病例达到15665730例(新增85108例),死亡531687例(新增1314例)。

△全球各地区新冠肺炎死亡病例数(图片来源:世卫组织)

世卫组织(WHO)称全球已有近200种新冠疫苗进入临床或临床前试验阶段 预计2021年底提供20亿剂疫苗

世卫组织总干事谭德塞21号在日内瓦举行的新冠肺炎例行新闻发布会上表示,全球目前已有近200种新冠疫苗进入临床或临床前试验阶段,目标是到2021年底提供20亿剂疫苗,而“获得抗击新冠肺炎工具加速器”国际合作倡议仍面临350亿美元资金缺口以扩大规模。

世界卫生组织总干事谭德塞当天在发布会上表示,世卫组织已与全球疫苗免疫联盟以及流行病预防创新联盟共同建立了“新冠肺炎疫苗实施计划”,旨在让参与国能够使用世界上最广泛和最多样化的候选疫苗产品组合,确保所有国家都能同时获得新冠疫苗,并优先考虑包括卫生工作者、老年人在内的高风险人群。谭德塞说:“目前已有近200种新冠疫苗进入临床或临床前试验阶段。疫苗研发的历史经验告诉我们,有些会失败,有些会成功。我们不能保证目前正在研发的每一种疫苗都可以使用,但候选疫苗越多,我们拥有安全有效疫苗的机会就越高。”

谭德塞指出,“新冠肺炎疫苗实施计划”可以实现全球协调部署,将有助于控制新冠肺炎大流行,挽救生命,加速经济复苏。“这不是慈善事业,而是(符合)每个国家的最大利益。结束新冠肺炎大流行和加速全球经济复苏的最快途径是确保在所有国家都有一部分人接种新冠疫苗,而不是在一些国家的所有人(接种)。最新民意调查显示,绝大多数人支持公平使用疫苗。我们的目标是到2021年底提供20亿剂疫苗。”

欧洲一些国家出现了第二波疫情,感染人数可比第一波,但死亡数却大大减少

 

  图:西班牙虽然出现了第二波疫情,但是死亡并没有出现明显的第二波死亡

 图:西班牙虽然出现了第二波疫情,但是死亡并没有出现明显的第二波死亡

美洲:美国新冠确诊病例数超685万 疫情形势恶化

数据显示,美国是全球累计确诊和累计死亡病例数最多的国家。美国约翰斯·霍普金斯大学数据显示,美国迄今累计超过685万人确诊感染新冠病毒,死亡病例数接近20万。

美国新冠疫情形势出现恶化。在截至当地时间20日的过去一周中,美国新增新冠确诊病例增加了约17%,新增死亡病例增加了5.5%。在美国全国范围中,有13个州的单周新增确诊病例已连续两周出现上涨。美国公共卫生专家认为,学校重启和劳动节派对是导致疫情扩散的主要原因。

当地时间21日,美国卫生部助理部长、白宫新冠疫情特别工作组成员吉罗尔表示,可以大面积投入使用的新冠疫苗要到2021年年中才会上市。他表示,疫苗研发不会受政治力量干预,一切以科学为准。

欧洲:俄单日新增病例超6000例 德国调整防疫措施以应对秋季疫情

据俄罗斯防疫指挥部21日消息,过去24小时俄新增新冠确诊病例6196例,累计确诊1109595例,累计死亡19489例,累计治愈911973例。

莫斯科谢东诺夫医科大学传染病学家卢卡舍夫等多名俄专家近日纷纷表示,单日新增病例数增多与职工返岗、学校开学有关,尚不能称之为第二波新冠疫情。莫斯科市长索比亚宁日前表示,莫斯科新冠疫情在可控范围之内,尚无需采取防疫限制新措施;超过6万名莫斯科居民申请参加俄新冠疫苗临床研究,其中已有700多人接种了疫苗。

德国联邦卫生部长施潘21日宣布对防疫策略进行调整,将采取设立发热门诊、开展快速抗体检测、实施隔离新规等措施以应对入秋后的疫情发展。另据德媒报道,现效力于英超曼城队的德国国脚、土耳其裔球星京多安当天被宣布确诊感染新冠病毒,成为首名确诊感染的德国国家足球队成员。

亚洲:乌兹别克斯坦副总理因新冠去世 韩国单日新增病例连续三天低于百例

据乌兹别克斯坦国家通讯社报道,乌副总理乌克塔姆·巴尔诺耶夫当地时间20日因新冠肺炎去世。他于7月底确诊新冠肺炎,后赴德国接受治疗,因病情危重不幸去世。8月末,该国布哈拉州州长卡里姆·卡马洛夫因新冠肺炎去世。

据印度卫生部21日公布的数据,印度过去24小时新增确诊86961例,累计升至5487580例;新增死亡1130例,累计死亡87882例。

孟加拉国卫生部门21日公布的新冠疫情数据显示,该国24小时内新增确诊病例1705例,累计确诊超35万例。孟政府21日正式允许有关医院、实验室等进行新冠病毒抗原检测。孟信息部同一日宣布,该国影院10月16日起将可恢复营业。

韩国中央防疫对策本部22日通报,自当地时间21日零时至22日零时,韩国新增感染新型冠状病毒确诊病例61例,单日新增病例连续三天保持在两位数的水平,并呈现逐日递减势头。然而学校、医院等地零星出现群聚性感染,加上感染途径不明的病例比重仍然高于25%,疫情随时可再次出现反弹。

以色列卫生部21日宣布,由于最近新冠发病率以及新冠病房承载量“异常增加”,该国所有医院将进入紧急状态。以卫生部总干事赫齐·莱维当日表示,以色列卫生系统将在数周甚至数天内“达到容量极限”。

非洲及大洋洲:非洲累计确诊数超140万 新西兰降低防疫响应等级

据非洲疾控中心官网最新数据,非洲地区累计确诊人数超140万,其中死亡33954人。

新西兰总理阿德恩21日宣布,经内阁讨论决定,由于新冠疫情得到有效控制,除最大城市奥克兰外,全国其他地区的疫情防控响应等级将从21日23时59分起从目前的2级降至1级,社会和经济活动将基本恢复正常。

此外,新西兰副总理兼外交部长温斯顿·彼得斯21日宣布,新西兰政府已承诺通过世界卫生组织主导的COVAX全球新冠疫苗计划投资2700万新西兰元(约合1830万美元),用于新冠疫苗研发。

美国疾控中心建议取消今年万圣节trick-or-treat和室内活动,不建议佩戴道具口罩

随着10月份万圣节临近,美国疾控中心(CDC)已发布包括万圣节在内的假期防疫指南。CDC在官网上更新写道,由于新冠大流行,今年不鼓励举办万圣节传统活动,例如门到门的trick-or-treat,或者化妆舞会等。同时指出道具口罩不能取代防护口罩,并警告不要在防护口罩外叠加佩戴道具口罩,这可能会导致呼吸困难。

指南将万圣节活动划分为高中低三个等级的风险程度。
低分险活动:雕刻南瓜、装饰房屋、户外寻宝、虚拟服装比赛,家庭成员一起看电影;
中风险活动:露天服装游行,户外服装派对,参与者至少保持6英尺社交距离;
高风险活动:挨家挨户要糖果、参加室内鬼屋或者派对。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=889352, encodeId=d70b88935258, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Wed Sep 30 09:51:55 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889054, encodeId=b8218890546c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Tue Sep 29 03:19:33 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888620, encodeId=561a88862076, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Sun Sep 27 00:35:16 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888139, encodeId=4c3488813995, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Sep 25 03:03:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887821, encodeId=f5d088e82153, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Sep 24 05:59:52 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887612, encodeId=9da188e612dd, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>不恐惧,不放松, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 23 10:32:41 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028582, encodeId=cef9102858280, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Sep 23 09:50:46 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887571, encodeId=6ad588e57102, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/098c25cdb5154e1bb182786b2533926f/3419b45692074173b9959a84e383add2.jpeg, createdBy=65775420680, createdName=希波克拉没有底, createdTime=Wed Sep 23 07:18:43 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887568, encodeId=169d88e56806, content=讲的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/f12d6e9599b34da9a3b19e067d551158/c198e8b957784a18bada633f29f6080e.jpg, createdBy=991c5420748, createdName=卡小陆, createdTime=Wed Sep 23 07:16:14 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887564, encodeId=b9a488e56477, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea5415858, createdName=ms1000001919017604, createdTime=Wed Sep 23 07:10:06 CST 2020, time=2020-09-23, status=1, ipAttribution=)]
    2020-09-30 1581f8c42cm

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=889352, encodeId=d70b88935258, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Wed Sep 30 09:51:55 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889054, encodeId=b8218890546c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Tue Sep 29 03:19:33 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888620, encodeId=561a88862076, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Sun Sep 27 00:35:16 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888139, encodeId=4c3488813995, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Sep 25 03:03:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887821, encodeId=f5d088e82153, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Sep 24 05:59:52 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887612, encodeId=9da188e612dd, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>不恐惧,不放松, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 23 10:32:41 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028582, encodeId=cef9102858280, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Sep 23 09:50:46 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887571, encodeId=6ad588e57102, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/098c25cdb5154e1bb182786b2533926f/3419b45692074173b9959a84e383add2.jpeg, createdBy=65775420680, createdName=希波克拉没有底, createdTime=Wed Sep 23 07:18:43 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887568, encodeId=169d88e56806, content=讲的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/f12d6e9599b34da9a3b19e067d551158/c198e8b957784a18bada633f29f6080e.jpg, createdBy=991c5420748, createdName=卡小陆, createdTime=Wed Sep 23 07:16:14 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887564, encodeId=b9a488e56477, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea5415858, createdName=ms1000001919017604, createdTime=Wed Sep 23 07:10:06 CST 2020, time=2020-09-23, status=1, ipAttribution=)]
    2020-09-29 1581f8c42cm

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=889352, encodeId=d70b88935258, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Wed Sep 30 09:51:55 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889054, encodeId=b8218890546c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Tue Sep 29 03:19:33 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888620, encodeId=561a88862076, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Sun Sep 27 00:35:16 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888139, encodeId=4c3488813995, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Sep 25 03:03:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887821, encodeId=f5d088e82153, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Sep 24 05:59:52 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887612, encodeId=9da188e612dd, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>不恐惧,不放松, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 23 10:32:41 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028582, encodeId=cef9102858280, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Sep 23 09:50:46 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887571, encodeId=6ad588e57102, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/098c25cdb5154e1bb182786b2533926f/3419b45692074173b9959a84e383add2.jpeg, createdBy=65775420680, createdName=希波克拉没有底, createdTime=Wed Sep 23 07:18:43 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887568, encodeId=169d88e56806, content=讲的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/f12d6e9599b34da9a3b19e067d551158/c198e8b957784a18bada633f29f6080e.jpg, createdBy=991c5420748, createdName=卡小陆, createdTime=Wed Sep 23 07:16:14 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887564, encodeId=b9a488e56477, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea5415858, createdName=ms1000001919017604, createdTime=Wed Sep 23 07:10:06 CST 2020, time=2020-09-23, status=1, ipAttribution=)]
    2020-09-27 1581f8c42cm

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=889352, encodeId=d70b88935258, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Wed Sep 30 09:51:55 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889054, encodeId=b8218890546c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Tue Sep 29 03:19:33 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888620, encodeId=561a88862076, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Sun Sep 27 00:35:16 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888139, encodeId=4c3488813995, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Sep 25 03:03:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887821, encodeId=f5d088e82153, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Sep 24 05:59:52 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887612, encodeId=9da188e612dd, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>不恐惧,不放松, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 23 10:32:41 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028582, encodeId=cef9102858280, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Sep 23 09:50:46 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887571, encodeId=6ad588e57102, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/098c25cdb5154e1bb182786b2533926f/3419b45692074173b9959a84e383add2.jpeg, createdBy=65775420680, createdName=希波克拉没有底, createdTime=Wed Sep 23 07:18:43 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887568, encodeId=169d88e56806, content=讲的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/f12d6e9599b34da9a3b19e067d551158/c198e8b957784a18bada633f29f6080e.jpg, createdBy=991c5420748, createdName=卡小陆, createdTime=Wed Sep 23 07:16:14 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887564, encodeId=b9a488e56477, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea5415858, createdName=ms1000001919017604, createdTime=Wed Sep 23 07:10:06 CST 2020, time=2020-09-23, status=1, ipAttribution=)]
    2020-09-25 1581f8c42cm

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=889352, encodeId=d70b88935258, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Wed Sep 30 09:51:55 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889054, encodeId=b8218890546c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Tue Sep 29 03:19:33 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888620, encodeId=561a88862076, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Sun Sep 27 00:35:16 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888139, encodeId=4c3488813995, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Sep 25 03:03:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887821, encodeId=f5d088e82153, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Sep 24 05:59:52 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887612, encodeId=9da188e612dd, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>不恐惧,不放松, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 23 10:32:41 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028582, encodeId=cef9102858280, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Sep 23 09:50:46 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887571, encodeId=6ad588e57102, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/098c25cdb5154e1bb182786b2533926f/3419b45692074173b9959a84e383add2.jpeg, createdBy=65775420680, createdName=希波克拉没有底, createdTime=Wed Sep 23 07:18:43 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887568, encodeId=169d88e56806, content=讲的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/f12d6e9599b34da9a3b19e067d551158/c198e8b957784a18bada633f29f6080e.jpg, createdBy=991c5420748, createdName=卡小陆, createdTime=Wed Sep 23 07:16:14 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887564, encodeId=b9a488e56477, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea5415858, createdName=ms1000001919017604, createdTime=Wed Sep 23 07:10:06 CST 2020, time=2020-09-23, status=1, ipAttribution=)]
    2020-09-24 1581f8c42cm

    学习

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=889352, encodeId=d70b88935258, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Wed Sep 30 09:51:55 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889054, encodeId=b8218890546c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Tue Sep 29 03:19:33 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888620, encodeId=561a88862076, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Sun Sep 27 00:35:16 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888139, encodeId=4c3488813995, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Sep 25 03:03:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887821, encodeId=f5d088e82153, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Sep 24 05:59:52 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887612, encodeId=9da188e612dd, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>不恐惧,不放松, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 23 10:32:41 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028582, encodeId=cef9102858280, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Sep 23 09:50:46 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887571, encodeId=6ad588e57102, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/098c25cdb5154e1bb182786b2533926f/3419b45692074173b9959a84e383add2.jpeg, createdBy=65775420680, createdName=希波克拉没有底, createdTime=Wed Sep 23 07:18:43 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887568, encodeId=169d88e56806, content=讲的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/f12d6e9599b34da9a3b19e067d551158/c198e8b957784a18bada633f29f6080e.jpg, createdBy=991c5420748, createdName=卡小陆, createdTime=Wed Sep 23 07:16:14 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887564, encodeId=b9a488e56477, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea5415858, createdName=ms1000001919017604, createdTime=Wed Sep 23 07:10:06 CST 2020, time=2020-09-23, status=1, ipAttribution=)]
    2020-09-23 lovetcm

    #新冠肺炎#不恐惧,不放松

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=889352, encodeId=d70b88935258, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Wed Sep 30 09:51:55 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889054, encodeId=b8218890546c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Tue Sep 29 03:19:33 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888620, encodeId=561a88862076, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Sun Sep 27 00:35:16 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888139, encodeId=4c3488813995, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Sep 25 03:03:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887821, encodeId=f5d088e82153, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Sep 24 05:59:52 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887612, encodeId=9da188e612dd, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>不恐惧,不放松, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 23 10:32:41 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028582, encodeId=cef9102858280, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Sep 23 09:50:46 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887571, encodeId=6ad588e57102, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/098c25cdb5154e1bb182786b2533926f/3419b45692074173b9959a84e383add2.jpeg, createdBy=65775420680, createdName=希波克拉没有底, createdTime=Wed Sep 23 07:18:43 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887568, encodeId=169d88e56806, content=讲的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/f12d6e9599b34da9a3b19e067d551158/c198e8b957784a18bada633f29f6080e.jpg, createdBy=991c5420748, createdName=卡小陆, createdTime=Wed Sep 23 07:16:14 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887564, encodeId=b9a488e56477, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea5415858, createdName=ms1000001919017604, createdTime=Wed Sep 23 07:10:06 CST 2020, time=2020-09-23, status=1, ipAttribution=)]
    2020-09-23 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=889352, encodeId=d70b88935258, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Wed Sep 30 09:51:55 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889054, encodeId=b8218890546c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Tue Sep 29 03:19:33 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888620, encodeId=561a88862076, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Sun Sep 27 00:35:16 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888139, encodeId=4c3488813995, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Sep 25 03:03:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887821, encodeId=f5d088e82153, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Sep 24 05:59:52 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887612, encodeId=9da188e612dd, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>不恐惧,不放松, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 23 10:32:41 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028582, encodeId=cef9102858280, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Sep 23 09:50:46 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887571, encodeId=6ad588e57102, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/098c25cdb5154e1bb182786b2533926f/3419b45692074173b9959a84e383add2.jpeg, createdBy=65775420680, createdName=希波克拉没有底, createdTime=Wed Sep 23 07:18:43 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887568, encodeId=169d88e56806, content=讲的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/f12d6e9599b34da9a3b19e067d551158/c198e8b957784a18bada633f29f6080e.jpg, createdBy=991c5420748, createdName=卡小陆, createdTime=Wed Sep 23 07:16:14 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887564, encodeId=b9a488e56477, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea5415858, createdName=ms1000001919017604, createdTime=Wed Sep 23 07:10:06 CST 2020, time=2020-09-23, status=1, ipAttribution=)]
    2020-09-23 希波克拉没有底

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=889352, encodeId=d70b88935258, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Wed Sep 30 09:51:55 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889054, encodeId=b8218890546c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Tue Sep 29 03:19:33 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888620, encodeId=561a88862076, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Sun Sep 27 00:35:16 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888139, encodeId=4c3488813995, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Sep 25 03:03:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887821, encodeId=f5d088e82153, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Sep 24 05:59:52 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887612, encodeId=9da188e612dd, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>不恐惧,不放松, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 23 10:32:41 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028582, encodeId=cef9102858280, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Sep 23 09:50:46 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887571, encodeId=6ad588e57102, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/098c25cdb5154e1bb182786b2533926f/3419b45692074173b9959a84e383add2.jpeg, createdBy=65775420680, createdName=希波克拉没有底, createdTime=Wed Sep 23 07:18:43 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887568, encodeId=169d88e56806, content=讲的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/f12d6e9599b34da9a3b19e067d551158/c198e8b957784a18bada633f29f6080e.jpg, createdBy=991c5420748, createdName=卡小陆, createdTime=Wed Sep 23 07:16:14 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887564, encodeId=b9a488e56477, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea5415858, createdName=ms1000001919017604, createdTime=Wed Sep 23 07:10:06 CST 2020, time=2020-09-23, status=1, ipAttribution=)]
    2020-09-23 卡小陆

    讲的好

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=889352, encodeId=d70b88935258, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Wed Sep 30 09:51:55 CST 2020, time=2020-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=889054, encodeId=b8218890546c, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Tue Sep 29 03:19:33 CST 2020, time=2020-09-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888620, encodeId=561a88862076, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Sun Sep 27 00:35:16 CST 2020, time=2020-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=888139, encodeId=4c3488813995, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Fri Sep 25 03:03:45 CST 2020, time=2020-09-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887821, encodeId=f5d088e82153, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200814/81d08245657a4a7f9a1ef713c0ec5878/ec4b201a22194a319b1aeb171bc6bb3d.jpg, createdBy=41e02111625, createdName=1581f8c42cm, createdTime=Thu Sep 24 05:59:52 CST 2020, time=2020-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887612, encodeId=9da188e612dd, content=<a href='/topic/show?id=46ce580e865' target=_blank style='color:#2F92EE;'>#新冠肺炎#</a>不恐惧,不放松, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58078, encryptionId=46ce580e865, topicName=新冠肺炎)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Wed Sep 23 10:32:41 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028582, encodeId=cef9102858280, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Wed Sep 23 09:50:46 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887571, encodeId=6ad588e57102, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200922/098c25cdb5154e1bb182786b2533926f/3419b45692074173b9959a84e383add2.jpeg, createdBy=65775420680, createdName=希波克拉没有底, createdTime=Wed Sep 23 07:18:43 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887568, encodeId=169d88e56806, content=讲的好, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200923/f12d6e9599b34da9a3b19e067d551158/c198e8b957784a18bada633f29f6080e.jpg, createdBy=991c5420748, createdName=卡小陆, createdTime=Wed Sep 23 07:16:14 CST 2020, time=2020-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=887564, encodeId=b9a488e56477, content=好用, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0ea5415858, createdName=ms1000001919017604, createdTime=Wed Sep 23 07:10:06 CST 2020, time=2020-09-23, status=1, ipAttribution=)]
    2020-09-23 ms1000001919017604

    好用

    0

相关资讯

N Engl J Med :张锋首次发表NEJM论文,发布升级版SHERLOCK系统,加速新冠检测

2020年2月14日,CRISPR基因编辑大神张锋教授团队发布了使用基于CRISPR/Cas13的SHERLOCK技术检测新型冠状病毒的详细操作流程文档。

Cell Dis:南京大学李靓/张辰宇团队等在金银花防新冠研究中再取新成果

金银花煎剂中吸收的MIR2911充分且必要地抑制体外和人类受试者中的SARS-CoV-2复制,因此,希望人们可以放弃对传统医学的偏见,并进行临床追踪,以帮助控制新冠疫情大流行。

9月20日全球新冠肺炎(COVID-19)疫情简报,确诊超3096万例,病毒有22种稳定突变

Worldometers世界实时统计数据显示,截至北京时间9月20日6时38分,全球新冠肺炎累计确诊病例突破3096万例,达到30,969,967例,累计死亡病例超过96万例,达到960,705例,康

9月21日全球新冠肺炎(COVID-19)疫情简报,确诊超3121万,第二波疫情明显到来

Worldometers世界实时统计数据显示,截至北京时间9月21日5时38分,全球新冠肺炎(COVID-19)累计确诊病例突破3121万例,达到31,216,782例,累计死亡病例超过96.4万例,

9月22日全球新冠肺炎(COVID-19)疫情简报,确诊超3145万,世界何时才能对外开放?

据Worldometers实时统计数据显示,截至北京时间9月22日06时47分,全球新冠肺炎(COVID-19)确诊病例达3145万例,新增209,288例至31,454,116例,死亡病例达96万例

9月19日全球新冠肺炎(COVID-19)疫情简报,确诊超3068万,日增30万将成为常态

据Worldometers实时统计数据显示,截至北京时间9月19日07时58分,全球新冠病毒确诊病例达3068万例,新增311,161例至30,682,518例,死亡病例达95万例,新增5,389例至